secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001493152-23-038003
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical acquires nanOss production ops from RTI Surgical for $2M cash plus contingent payments
--------------------------------------------------------------------------------

- Acquired equipment and inventory from RTI Surgical's synthetic bone graft business for $2M cash plus contingent payments based on future nanOss product sales.
- Assumed lease for the nanOss production facility in Greenville, NC.
- Previously acquired nanOss distribution rights and IP from Surgalign in August 2023.
- CEO Sean Browne says full control will revive and grow nanOss, improving manufacturing capabilities and cash flows.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/0001493152-23-038003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer